National Healthcare [NHC] vs Aveanna Healthcare [AVAH] Detailed Stock Comparison
National Healthcare
NYSE
Loading...
Aveanna Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: National Healthcare wins in 11 metrics, Aveanna Healthcare wins in 8 metrics, with 0 ties. National Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | National Healthcare | Aveanna Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.41 | 96.22 | National Healthcare |
| Price-to-Book Ratio | 1.81 | -154.18 | Aveanna Healthcare |
| Debt-to-Equity Ratio | 16.83 | -132.41 | Aveanna Healthcare |
| PEG Ratio | -1.53 | 1.12 | National Healthcare |
| EV/EBITDA | 11.31 | 13.78 | National Healthcare |
| Profit Margin (TTM) | 7.19% | 0.85% | National Healthcare |
| Operating Margin (TTM) | 9.09% | 14.15% | Aveanna Healthcare |
| EBITDA Margin (TTM) | 9.09% | 14.15% | Aveanna Healthcare |
| Return on Equity | 10.66% | 8.95% | National Healthcare |
| Return on Assets (TTM) | 5.02% | 8.12% | Aveanna Healthcare |
| Free Cash Flow (TTM) | $79.70M | $26.32M | National Healthcare |
| Dividend Yield | 2.30% | N/A | N/A |
| 1-Year Return | -0.99% | 91.17% | Aveanna Healthcare |
| Price-to-Sales Ratio (TTM) | 1.31 | 0.83 | Aveanna Healthcare |
| Enterprise Value | $1.82B | $3.20B | Aveanna Healthcare |
| EV/Revenue Ratio | 1.25 | 1.47 | National Healthcare |
| Gross Profit Margin (TTM) | 39.58% | 35.76% | National Healthcare |
| Revenue per Share (TTM) | $94 | $11 | National Healthcare |
| Earnings per Share (Diluted) | $6.49 | $0.09 | National Healthcare |
| Beta (Stock Volatility) | 0.59 | 2.05 | National Healthcare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
National Healthcare vs Aveanna Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| National Healthcare | -2.28% | -0.39% | 8.24% | 11.99% | 29.92% | 14.39% |
| Aveanna Healthcare | -3.56% | 2.36% | 5.10% | 94.17% | 54.09% | 92.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| National Healthcare | -0.99% | 99.67% | 86.32% | 90.55% | 230.62% | 244.07% |
| Aveanna Healthcare | 91.17% | 556.06% | -25.86% | -25.86% | -25.86% | -25.86% |
News Based Sentiment: National Healthcare vs Aveanna Healthcare
National Healthcare
News based Sentiment: MIXED
September brought both positive and negative developments for NHC, including a dividend payout and analyst upgrade offset by a lease default notice and a leadership transition. The mixed financial results and analyst sentiment further contribute to a complex investment picture, making this a significant month for the company.
Aveanna Healthcare
News based Sentiment: POSITIVE
Aveanna is experiencing a period of strong positive momentum, driven by favorable rate increases, analyst upgrades, and significant institutional investment. The company's financial performance is improving, and it is strategically positioned for continued growth in the expanding in-home care market.
Performance & Financial Health Analysis: National Healthcare vs Aveanna Healthcare
| Metric | NHC | AVAH |
|---|---|---|
| Market Information | ||
| Market Cap | $1.94B | $1.80B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 121,091 | 1,401,890 |
| 90 Day Avg. Volume | 68,850 | 1,327,413 |
| Last Close | $121.80 | $8.66 |
| 52 Week Range | $89.14 - $136.86 | $3.67 - $9.03 |
| % from 52W High | -11.00% | -4.10% |
| All-Time High | $138.49 (Jul 29, 2024) | $13.00 (Jun 14, 2021) |
| % from All-Time High | -12.05% | -33.38% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.29% | 0.17% |
| Quarterly Earnings Growth | -0.12% | 0.94% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.01% |
| Operating Margin (TTM) | 0.09% | 0.14% |
| Return on Equity (TTM) | 0.11% | 0.09% |
| Debt to Equity (MRQ) | 16.83 | -132.41 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $65.93 | $-0.05 |
| Cash per Share (MRQ) | $16.62 | $0.48 |
| Operating Cash Flow (TTM) | $149.07M | $85.74M |
| Levered Free Cash Flow (TTM) | $100.15M | $68.41M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.30% | N/A |
| Last 12-Month Dividend | $2.44 | N/A |
Valuation & Enterprise Metrics Analysis: National Healthcare vs Aveanna Healthcare
| Metric | NHC | AVAH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.41 | 96.22 |
| Forward P/E | 277.79 | 173.20 |
| PEG Ratio | -1.53 | 1.12 |
| Price to Sales (TTM) | 1.31 | 0.83 |
| Price to Book (MRQ) | 1.81 | -154.18 |
| Market Capitalization | ||
| Market Capitalization | $1.94B | $1.80B |
| Enterprise Value | $1.82B | $3.20B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.25 | 1.47 |
| Enterprise to EBITDA | 11.31 | 13.78 |
| Risk & Other Metrics | ||
| Beta | 0.59 | 2.05 |
| Book Value per Share (MRQ) | $65.93 | $-0.05 |
Financial Statements Comparison: National Healthcare vs Aveanna Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NHC | AVAH |
|---|---|---|
| Revenue/Sales | $373.70M | $589.55M |
| Cost of Goods Sold | $228.13M | $378.75M |
| Gross Profit | $145.57M | $210.80M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $30.77M | $83.43M |
| EBITDA | $43.87M | $90.44M |
| Pre-Tax Income | $43.72M | $44.14M |
| Income Tax | $11.43M | $17.11M |
| Net Income (Profit) | $32.29M | $27.03M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NHC | AVAH |
|---|---|---|
| Cash & Equivalents | $90.39M | $71.49M |
| Total Current Assets | $455.20M | $407.62M |
| Total Current Liabilities | $239.23M | $388.31M |
| Long-Term Debt | $163.31M | $1.30B |
| Total Shareholders Equity | $1.01B | $-98.67M |
| Retained Earnings | $774.95M | $-1.38B |
| Property, Plant & Equipment | $1.36B | $57.50M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NHC | AVAH |
|---|---|---|
| Operating Cash Flow | $47.95M | $-16.22M |
| Capital Expenditures | $-6.14M | $-2.35M |
| Free Cash Flow | $33.12M | $-10.98M |
| Debt Repayment | $-3.00M | $-5.06M |
| Common Stock Repurchase | $-1.72M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NHC | AVAH |
|---|---|---|
| Shares Short | 259,597 | 5.08M |
| Short Ratio | 6.59 | 3.87 |
| Short % of Float | 0.03% | 0.07% |
| Average Daily Volume (10 Day) | 121,091 | 1,401,890 |
| Average Daily Volume (90 Day) | 68,850 | 1,327,413 |
| Shares Outstanding | 15.45M | 193.23M |
| Float Shares | 12.46M | 57.71M |
| % Held by Insiders | 0.19% | 0.06% |
| % Held by Institutions | 0.59% | 0.89% |
Dividend Analysis & Yield Comparison: National Healthcare vs Aveanna Healthcare
| Metric | NHC | AVAH |
|---|---|---|
| Last 12-Month Dividend | $2.44 | N/A |
| Last 12-Month Dividend Yield | 2.30% | N/A |
| 3-Year Avg Annual Dividend | $2.36 | N/A |
| 3-Year Avg Dividend Yield | 0.75% | N/A |
| 3-Year Total Dividends | $7.08 | N/A |
| Ex-Dividend Date | Mar 28, 2025 | N/A |